St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
Not Applicable
Not yet recruiting
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06797583
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Phase 1
Recruiting
- Conditions
- Acute Lymphoblastic LeukemiaRecurrent Acute Lymphoblastic LeukemiaRecurrent B Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06777979
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Phase 2
Recruiting
- Conditions
- Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT06847269
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Not Applicable
Recruiting
- Conditions
- Muscle WeaknessChildhood Cancer
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06819475
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
Phase 1
Recruiting
- Conditions
- LeukemiaAcute Myeloid LeukemiaLymphoblastic Leukemia in Children
- Interventions
- Drug: Fluoroquinolone (either ciprofloxacin or levofloxacin at the discretion of the treating clinician)
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT06810583
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Not Applicable
Recruiting
- Conditions
- Childhood Cancer
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 188
- Registration Number
- NCT06747910
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
Recruiting
- Conditions
- Hemoglobin Disorder
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06646640
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Recruiting
- Conditions
- B-ALLHematologic MalignancySolid Tumor
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06579469
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Phase 2
Recruiting
- Conditions
- Lymphoblastic LymphomaAcute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT06533748
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
Recruiting
- Conditions
- Spinal Muscular Atrophy
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06532474
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath